{"transactions":[{"id":670904,"issuer":{"id":7653,"kind":"organization","name":"Chemomab Therapeutics Ltd."},"owners":[{"id":17866,"kind":"person","name":"Cohen Neil Harris","position":1,"cik":"0001840006","reported_name":"Cohen Neil Harris","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock option (right to buy American Depositary Shares)","published_at":"2026-09-01T14:05:49.000Z","date":"2026-03-16","kind":"grant","planned":false,"acquired":true,"shares":5172,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":18075,"derivative":{"exercise_price":2.14,"exercise_date":"2027-03-16","expiration_date":"2036-03-16","underlying":"American Depositary Shares","underlying_shares":5172},"source":{"system":"sec-edgar","filing":"0001178913-26-004371","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1534248/000117891326004371/ownership.xml","form_type":"4"}},{"id":670903,"issuer":{"id":7653,"kind":"organization","name":"Chemomab Therapeutics Ltd."},"owners":[{"id":17866,"kind":"person","name":"Cohen Neil Harris","position":1,"cik":"0001840006","reported_name":"Cohen Neil Harris","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock option (right to buy American Depositary Shares)","published_at":"2026-09-01T14:05:49.000Z","date":"2025-03-16","kind":"grant","planned":false,"acquired":true,"shares":3821,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The options reported in this row were granted to the Reporting Person by the Issuer on March 16, 2025, and are fully vested and exercisable as of the date of this report."}],"balance_after":12903,"derivative":{"exercise_price":6.16,"expiration_date":"2035-03-16","underlying":"American Depositary Shares","underlying_shares":3821},"source":{"system":"sec-edgar","filing":"0001178913-26-004371","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1534248/000117891326004371/ownership.xml","form_type":"4"}},{"id":670902,"issuer":{"id":7653,"kind":"organization","name":"Chemomab Therapeutics Ltd."},"owners":[{"id":17866,"kind":"person","name":"Cohen Neil Harris","position":1,"cik":"0001840006","reported_name":"Cohen Neil Harris","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock option (right to buy American Depositary Shares)","published_at":"2026-09-01T14:05:49.000Z","date":"2024-03-18","kind":"grant","planned":false,"acquired":true,"shares":2520,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The options reported in this row were granted to the Reporting Person by the Issuer on March 18, 2024, and are fully vested and exercisable as of the date of this report."}],"balance_after":9082,"derivative":{"exercise_price":2.96,"expiration_date":"2034-03-18","underlying":"American Depositary Shares","underlying_shares":2520},"source":{"system":"sec-edgar","filing":"0001178913-26-004371","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1534248/000117891326004371/ownership.xml","form_type":"4"}},{"id":670901,"issuer":{"id":7653,"kind":"organization","name":"Chemomab Therapeutics Ltd."},"owners":[{"id":17866,"kind":"person","name":"Cohen Neil Harris","position":1,"cik":"0001840006","reported_name":"Cohen Neil Harris","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock option (right to buy American Depositary Shares)","published_at":"2026-09-01T14:05:49.000Z","date":"2023-03-21","kind":"grant","planned":false,"acquired":true,"shares":1714,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The options reported in this row were granted to the Reporting Person by the Issuer on March 21, 2023, and are fully vested and exercisable as of the date of this report."}],"balance_after":6562,"derivative":{"exercise_price":6.48,"expiration_date":"2033-03-21","underlying":"American Depositary Shares","underlying_shares":1714},"source":{"system":"sec-edgar","filing":"0001178913-26-004371","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1534248/000117891326004371/ownership.xml","form_type":"4"}},{"id":670900,"issuer":{"id":7653,"kind":"organization","name":"Chemomab Therapeutics Ltd."},"owners":[{"id":17866,"kind":"person","name":"Cohen Neil Harris","position":1,"cik":"0001840006","reported_name":"Cohen Neil Harris","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock option (right to buy American Depositary Shares)","published_at":"2026-09-01T14:05:49.000Z","date":"2022-03-07","kind":"grant","planned":false,"acquired":true,"shares":1705,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The options reported in this row were granted to the Reporting Person by the Issuer on March 7, 2022, and are fully vested and exercisable as of the date of this report."}],"balance_after":4848,"derivative":{"exercise_price":14.12,"expiration_date":"2032-03-07","underlying":"American Depositary Shares","underlying_shares":1705},"source":{"system":"sec-edgar","filing":"0001178913-26-004371","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1534248/000117891326004371/ownership.xml","form_type":"4"}},{"id":670899,"issuer":{"id":7653,"kind":"organization","name":"Chemomab Therapeutics Ltd."},"owners":[{"id":17866,"kind":"person","name":"Cohen Neil Harris","position":1,"cik":"0001840006","reported_name":"Cohen Neil Harris","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock option (right to buy American Depositary Shares)","published_at":"2026-09-01T14:05:49.000Z","date":"2021-04-19","kind":"grant","planned":false,"acquired":true,"shares":2971,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options reported in this row were granted to the Reporting Person by the Issuer on April 19, 2021, and are fully vested and exercisable as of the date of this report."}],"balance_after":3143,"derivative":{"exercise_price":109.04,"expiration_date":"2031-04-19","underlying":"American Depositary Shares","underlying_shares":2971},"source":{"system":"sec-edgar","filing":"0001178913-26-004371","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1534248/000117891326004371/ownership.xml","form_type":"4"}},{"id":670898,"issuer":{"id":7653,"kind":"organization","name":"Chemomab Therapeutics Ltd."},"owners":[{"id":17866,"kind":"person","name":"Cohen Neil Harris","position":1,"cik":"0001840006","reported_name":"Cohen Neil Harris","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock option (right to buy American Depositary Shares)","published_at":"2026-09-01T14:05:49.000Z","date":"2020-07-16","kind":"grant","planned":false,"acquired":true,"shares":172,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options reported in this row were granted to the Reporting Person by the Issuer on July 16, 2020, and are fully vested and exercisable as of the date of this report."}],"balance_after":172,"derivative":{"exercise_price":52.8,"expiration_date":"2030-07-16","underlying":"American Depositary Shares","underlying_shares":172},"source":{"system":"sec-edgar","filing":"0001178913-26-004371","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1534248/000117891326004371/ownership.xml","form_type":"4"}},{"id":670897,"issuer":{"id":7653,"kind":"organization","name":"Chemomab Therapeutics Ltd."},"owners":[{"id":17866,"kind":"person","name":"Cohen Neil Harris","position":1,"cik":"0001840006","reported_name":"Cohen Neil Harris","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"American Depositary Shares","published_at":"2026-09-01T14:05:49.000Z","date":"2026-08-28","kind":"sale","planned":false,"acquired":false,"shares":1000,"price":2.8,"value":2800.0,"ownership":{"direct":true},"balance_after":33000,"source":{"system":"sec-edgar","filing":"0001178913-26-004371","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1534248/000117891326004371/ownership.xml","form_type":"4"}},{"id":670896,"issuer":{"id":7653,"kind":"organization","name":"Chemomab Therapeutics Ltd."},"owners":[{"id":17866,"kind":"person","name":"Cohen Neil Harris","position":1,"cik":"0001840006","reported_name":"Cohen Neil Harris","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"American Depositary Shares","published_at":"2026-09-01T14:05:49.000Z","date":"2026-08-27","kind":"sale","planned":false,"acquired":false,"shares":1304,"price":2.85,"value":3716.4,"ownership":{"direct":true},"balance_after":34000,"source":{"system":"sec-edgar","filing":"0001178913-26-004371","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1534248/000117891326004371/ownership.xml","form_type":"4"}},{"id":1939979,"issuer":{"id":7653,"kind":"organization","name":"Chemomab Therapeutics Ltd."},"owners":[{"id":17866,"kind":"person","name":"Cohen Neil Harris","position":1,"cik":"0001840006","reported_name":"Cohen Neil Harris","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to Purchase American Depositary Shares","published_at":"2023-03-23T11:35:31.000Z","date":"2021-03-16","kind":"grant","planned":false,"acquired":true,"shares":688,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"No transaction has been effected by the Reporting Person with respect to these securities, and they are being included in this Form 4 for informational purposes only."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"These options vest and become exercisable as follows: 1/3 vested on July 16, 2021, and the remaining options vest on a quarterly basis for the following eight quarters, subject to the Reporting Person's continued service."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"Each American Depositary Share (ADS) represents twenty (20) ordinary shares, no par value, of the Issuer."}],"balance_after":688,"derivative":{"exercise_price":13.17,"expiration_date":"2030-07-15","underlying":"American Depositary Shares","underlying_shares":688},"source":{"system":"sec-edgar","filing":"0001178913-23-001111","document":"zk2329428.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1534248/000117891323001111/zk2329428.xml","form_type":"4"}},{"id":1939978,"issuer":{"id":7653,"kind":"organization","name":"Chemomab Therapeutics Ltd."},"owners":[{"id":17866,"kind":"person","name":"Cohen Neil Harris","position":1,"cik":"0001840006","reported_name":"Cohen Neil Harris","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to Purchase American Depositary Shares","published_at":"2023-03-23T11:35:31.000Z","date":"2021-04-19","kind":"grant","planned":false,"acquired":true,"shares":11884,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"No transaction has been effected by the Reporting Person with respect to these securities, and they are being included in this Form 4 for informational purposes only."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"These options vest and become exercisable in equal monthly installments over a 36 month period commencing on March 16, 2021, subject to the Reporting Person's continued service."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"Each American Depositary Share (ADS) represents twenty (20) ordinary shares, no par value, of the Issuer."}],"balance_after":11884,"derivative":{"exercise_price":27.26,"expiration_date":"2031-04-19","underlying":"American Depositary Shares","underlying_shares":11884},"source":{"system":"sec-edgar","filing":"0001178913-23-001111","document":"zk2329428.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1534248/000117891323001111/zk2329428.xml","form_type":"4"}},{"id":1939977,"issuer":{"id":7653,"kind":"organization","name":"Chemomab Therapeutics Ltd."},"owners":[{"id":17866,"kind":"person","name":"Cohen Neil Harris","position":1,"cik":"0001840006","reported_name":"Cohen Neil Harris","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to Purchase American Depositary Shares","published_at":"2023-03-23T11:35:31.000Z","date":"2022-03-07","kind":"grant","planned":false,"acquired":true,"shares":6820,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"No transaction has been effected by the Reporting Person with respect to these securities, and they are being included in this Form 4 for informational purposes only."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"These options vested and became exercisable in their entirety on March 16, 2023. These options were granted as per the annual grant of options to directors"},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"Each American Depositary Share (ADS) represents twenty (20) ordinary shares, no par value, of the Issuer."}],"balance_after":6820,"derivative":{"exercise_price":3.53,"expiration_date":"2032-03-07","underlying":"American Depositary Shares","underlying_shares":6820},"source":{"system":"sec-edgar","filing":"0001178913-23-001111","document":"zk2329428.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1534248/000117891323001111/zk2329428.xml","form_type":"4"}},{"id":1939976,"issuer":{"id":7653,"kind":"organization","name":"Chemomab Therapeutics Ltd."},"owners":[{"id":17866,"kind":"person","name":"Cohen Neil Harris","position":1,"cik":"0001840006","reported_name":"Cohen Neil Harris","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to Purchase American Depositary Shares","published_at":"2023-03-23T11:35:31.000Z","date":"2023-03-16","kind":"grant","planned":false,"acquired":true,"shares":6875,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"These options were granted as per the annual grant of options to directors. Those options vest and become exercisable in their entirety on March 16, 2024, subject to the Reporting Person's continued service."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"Each American Depositary Share (ADS) represents twenty (20) ordinary shares, no par value, of the Issuer."}],"balance_after":6875,"derivative":{"exercise_price":1.62,"expiration_date":"2033-03-21","underlying":"American Depositary Shares","underlying_shares":6875},"source":{"system":"sec-edgar","filing":"0001178913-23-001111","document":"zk2329428.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1534248/000117891323001111/zk2329428.xml","form_type":"4"}},{"id":2109989,"issuer":{"id":7653,"kind":"organization","name":"Chemomab Therapeutics Ltd."},"owners":[{"id":17866,"kind":"person","name":"Cohen Neil Harris","position":1,"cik":"0001840006","reported_name":"Cohen Neil Harris","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to Purchase American Depositary Shares","published_at":"2022-11-18T12:53:09.000Z","date":"2021-03-16","kind":"grant","acquired":true,"shares":688,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F4","text":"No transaction has been effected by the Reporting Person with respect to these securities, and they are being included in this Form 4 for informational purposes only."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"These options vest and become exercisable as follows: 1/3 vested on July 16, 2021, and the remaining options vest on a quarterly basis for the following eight quarters, subject to the Reporting Person's continued service."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"Each American Depositary Share (ADS) represents twenty (20) ordinary shares, no par value, of the Issuer."}],"balance_after":688,"derivative":{"exercise_price":13.17,"expiration_date":"2030-07-15","underlying":"American Depositary Shares","underlying_shares":688},"source":{"system":"sec-edgar","filing":"0001178913-22-004100","document":"zk2228788.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1534248/000117891322004100/zk2228788.xml","form_type":"4"}},{"id":2109988,"issuer":{"id":7653,"kind":"organization","name":"Chemomab Therapeutics Ltd."},"owners":[{"id":17866,"kind":"person","name":"Cohen Neil Harris","position":1,"cik":"0001840006","reported_name":"Cohen Neil Harris","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to Purchase American Depositary Shares","published_at":"2022-11-18T12:53:09.000Z","date":"2021-04-19","kind":"grant","acquired":true,"shares":11884,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F4","text":"No transaction has been effected by the Reporting Person with respect to these securities, and they are being included in this Form 4 for informational purposes only."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"These options vest and become exercisable in equal monthly installments over a 36 month period commencing on March 16, 2021, subject to the Reporting Person's continued service."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"Each American Depositary Share (ADS) represents twenty (20) ordinary shares, no par value, of the Issuer."}],"balance_after":11884,"derivative":{"exercise_price":27.26,"expiration_date":"2031-04-19","underlying":"American Depositary Shares","underlying_shares":11884},"source":{"system":"sec-edgar","filing":"0001178913-22-004100","document":"zk2228788.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1534248/000117891322004100/zk2228788.xml","form_type":"4"}},{"id":2109987,"issuer":{"id":7653,"kind":"organization","name":"Chemomab Therapeutics Ltd."},"owners":[{"id":17866,"kind":"person","name":"Cohen Neil Harris","position":1,"cik":"0001840006","reported_name":"Cohen Neil Harris","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to Purchase American Depositary Shares","published_at":"2022-11-18T12:53:09.000Z","date":"2022-03-07","kind":"grant","acquired":true,"shares":6820,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F4","text":"No transaction has been effected by the Reporting Person with respect to these securities, and they are being included in this Form 4 for informational purposes only."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"These options vest and become exercisable in their entirety on March 16, 2023 subject to the Reporting Person's continued service."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"Each American Depositary Share (ADS) represents twenty (20) ordinary shares, no par value, of the Issuer."}],"balance_after":6820,"derivative":{"exercise_price":3.53,"expiration_date":"2032-03-07","underlying":"American Depositary Shares","underlying_shares":6820},"source":{"system":"sec-edgar","filing":"0001178913-22-004100","document":"zk2228788.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1534248/000117891322004100/zk2228788.xml","form_type":"4"}},{"id":2109986,"issuer":{"id":7653,"kind":"organization","name":"Chemomab Therapeutics Ltd."},"owners":[{"id":17866,"kind":"person","name":"Cohen Neil Harris","position":1,"cik":"0001840006","reported_name":"Cohen Neil Harris","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"American Depositary Shares","published_at":"2022-11-18T12:53:09.000Z","date":"2022-11-16","kind":"sale","acquired":false,"shares":2409,"price":2,"value":4818.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each American Depositary Share (ADS) represents twenty (20) ordinary shares, no par value, of the Issuer."},{"field":"shares","element":"transactionShares","label":"F2","text":"The ADSs are held of record directly by the Phoenix Insurance Company Ltd. (Naftali Neil Cohen) (the \"IRA\"), which is self-managed by the Reporting Person. The Reporting Person is the sole beneficiary of the IRA and may be deemed to have sole voting and dispositive power with respect to the ADSs held by IRA."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Based upon the 12,409 ADSs previously held as reported by Mr. Neil Cohen on Form 4 filed with the SEC on May 19, 2022."}],"balance_after":10000,"source":{"system":"sec-edgar","filing":"0001178913-22-004100","document":"zk2228788.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1534248/000117891322004100/zk2228788.xml","form_type":"4"}},{"id":2263209,"issuer":{"id":7653,"kind":"organization","name":"Chemomab Therapeutics Ltd."},"owners":[{"id":17866,"kind":"person","name":"Cohen Neil Harris","position":1,"cik":"0001840006","reported_name":"Cohen Neil Harris","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to Purchase American Depositary Shares","published_at":"2022-05-19T20:02:33.000Z","date":"2021-03-16","kind":"grant","acquired":true,"shares":688,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F4","text":"No transaction has been effected by the Reporting Person with respect to these securities, and they are being included in this Form 4 for informational purposes only."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"These options vest and become exercisable as follows: 1/3 vested on July 16, 2021, and the remaining options vest on a quarterly basis for the following eight quarters, subject to the Reporting Person's continued service."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"Each American Depositary Share (ADS) represents twenty (20) ordinary shares, no par value, of the Issuer."}],"balance_after":688,"derivative":{"exercise_price":13.17,"expiration_date":"2030-07-15","underlying":"American Depositary Shares","underlying_shares":688},"source":{"system":"sec-edgar","filing":"0001178913-22-002093","document":"zk2227874.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1534248/000117891322002093/zk2227874.xml","form_type":"4"}},{"id":2263208,"issuer":{"id":7653,"kind":"organization","name":"Chemomab Therapeutics Ltd."},"owners":[{"id":17866,"kind":"person","name":"Cohen Neil Harris","position":1,"cik":"0001840006","reported_name":"Cohen Neil Harris","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to Purchase American Depositary Shares","published_at":"2022-05-19T20:02:33.000Z","date":"2021-04-19","kind":"grant","acquired":true,"shares":11884,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F4","text":"No transaction has been effected by the Reporting Person with respect to these securities, and they are being included in this Form 4 for informational purposes only."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"These options vest and become exercisable in equal monthly installments over a 36 month period commencing on March 16, 2021, subject to the Reporting Person's continued service."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"Each American Depositary Share (ADS) represents twenty (20) ordinary shares, no par value, of the Issuer."}],"balance_after":11884,"derivative":{"exercise_price":27.26,"expiration_date":"2031-04-19","underlying":"American Depositary Shares","underlying_shares":11884},"source":{"system":"sec-edgar","filing":"0001178913-22-002093","document":"zk2227874.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1534248/000117891322002093/zk2227874.xml","form_type":"4"}},{"id":2263207,"issuer":{"id":7653,"kind":"organization","name":"Chemomab Therapeutics Ltd."},"owners":[{"id":17866,"kind":"person","name":"Cohen Neil Harris","position":1,"cik":"0001840006","reported_name":"Cohen Neil Harris","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to Purchase American Depositary Shares","published_at":"2022-05-19T20:02:33.000Z","date":"2022-03-07","kind":"grant","acquired":true,"shares":6820,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F4","text":"No transaction has been effected by the Reporting Person with respect to these securities, and they are being included in this Form 4 for informational purposes only."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"These options vest and become exercisable in their entirety on March 16, 2023 subject to the Reporting Person's continued service."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"Each American Depositary Share (ADS) represents twenty (20) ordinary shares, no par value, of the Issuer."}],"balance_after":6820,"derivative":{"exercise_price":3.53,"expiration_date":"2032-03-07","underlying":"American Depositary Shares","underlying_shares":6820},"source":{"system":"sec-edgar","filing":"0001178913-22-002093","document":"zk2227874.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1534248/000117891322002093/zk2227874.xml","form_type":"4"}},{"id":2263206,"issuer":{"id":7653,"kind":"organization","name":"Chemomab Therapeutics Ltd."},"owners":[{"id":17866,"kind":"person","name":"Cohen Neil Harris","position":1,"cik":"0001840006","reported_name":"Cohen Neil Harris","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"American Depositary Shares","published_at":"2022-05-19T20:02:33.000Z","date":"2022-05-18","kind":"purchase","acquired":true,"shares":2000,"price":3.19,"value":6380.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each American Depositary Share (ADS) represents twenty (20) ordinary shares, no par value, of the Issuer."},{"field":"shares","element":"transactionShares","label":"F2","text":"The ADSs are held of record directly by the Phoenix Insurance Company Ltd. (Naftali Neil Cohen) (the \"IRA\"), which is self-managed by the Reporting Person. The Reporting Person is the sole beneficiary of the IRA and may be deemed to have sole voting and dispositive power with respect to the ADSs held by IRA."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes the previously reported 10,409 ADSs of the Company, as reported by Mr. Neil Cohen on Form 4 filed with the SEC on March 15, 2022."}],"balance_after":12409,"source":{"system":"sec-edgar","filing":"0001178913-22-002093","document":"zk2227874.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1534248/000117891322002093/zk2227874.xml","form_type":"4"}},{"id":2332765,"issuer":{"id":7653,"kind":"organization","name":"Chemomab Therapeutics Ltd."},"owners":[{"id":17866,"kind":"person","name":"Cohen Neil Harris","position":1,"cik":"0001840006","reported_name":"Cohen Neil Harris","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to Purchase American Depositary Shares","published_at":"2022-03-15T20:07:42.000Z","date":"2021-03-16","kind":"grant","acquired":true,"shares":688,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F3","text":"No transaction has been effected by the Reporting Person with respect to these securities, and they are being included in this Form 4 for informational purposes only."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"These options vest and become exercisable as follows: 1/3 vest on July 16, 2021, and the remaining options vest on a quarterly basis for the following eight quarters, subject to the Reporting Person's continued service."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"Each American Depositary Share (ADS) represents twenty (20) ordinary shares, no par value, of the Issuer."}],"balance_after":688,"derivative":{"exercise_price":13.17,"expiration_date":"2030-07-15","underlying":"American Depositary Shares","underlying_shares":688},"source":{"system":"sec-edgar","filing":"0001178913-22-001117","document":"zk2227487.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1534248/000117891322001117/zk2227487.xml","form_type":"4"}},{"id":2332764,"issuer":{"id":7653,"kind":"organization","name":"Chemomab Therapeutics Ltd."},"owners":[{"id":17866,"kind":"person","name":"Cohen Neil Harris","position":1,"cik":"0001840006","reported_name":"Cohen Neil Harris","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to Purchase American Depositary Shares","published_at":"2022-03-15T20:07:42.000Z","date":"2021-04-19","kind":"grant","acquired":true,"shares":11884,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F3","text":"No transaction has been effected by the Reporting Person with respect to these securities, and they are being included in this Form 4 for informational purposes only."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"These options vest and become exercisable in equal monthly installments over a 36 month period commencing on March 16, 2021, subject to the Reporting Person's continued service."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"Each American Depositary Share (ADS) represents twenty (20) ordinary shares, no par value, of the Issuer."}],"balance_after":11884,"derivative":{"exercise_price":27.26,"expiration_date":"2031-04-19","underlying":"American Depositary Shares","underlying_shares":11884},"source":{"system":"sec-edgar","filing":"0001178913-22-001117","document":"zk2227487.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1534248/000117891322001117/zk2227487.xml","form_type":"4"}},{"id":2332763,"issuer":{"id":7653,"kind":"organization","name":"Chemomab Therapeutics Ltd."},"owners":[{"id":17866,"kind":"person","name":"Cohen Neil Harris","position":1,"cik":"0001840006","reported_name":"Cohen Neil Harris","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to Purchase American Depositary Shares","published_at":"2022-03-15T20:07:42.000Z","date":"2022-03-07","kind":"grant","acquired":true,"shares":6820,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F3","text":"No transaction has been effected by the Reporting Person with respect to these securities, and they are being included in this Form 4 for informational purposes only."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"These options vest and become exercisable in their entirety on March 16, 2023 subject to the Reporting Person's continued service."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"Each American Depositary Share (ADS) represents twenty (20) ordinary shares, no par value, of the Issuer."}],"balance_after":6820,"derivative":{"exercise_price":3.53,"expiration_date":"2032-03-07","underlying":"American Depositary Shares","underlying_shares":6820},"source":{"system":"sec-edgar","filing":"0001178913-22-001117","document":"zk2227487.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1534248/000117891322001117/zk2227487.xml","form_type":"4"}},{"id":2332762,"issuer":{"id":7653,"kind":"organization","name":"Chemomab Therapeutics Ltd."},"owners":[{"id":17866,"kind":"person","name":"Cohen Neil Harris","position":1,"cik":"0001840006","reported_name":"Cohen Neil Harris","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"American Depositary Shares","published_at":"2022-03-15T20:07:42.000Z","date":"2022-03-14","kind":"purchase","acquired":true,"shares":2000,"price":4.56,"value":9120.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each American Depositary Share (ADS) represents twenty (20) ordinary shares, no par value, of the Issuer."},{"field":"shares","element":"transactionShares","label":"F2","text":"The ADSs are held of record directly by the Phoenix Insurance Company Ltd. (Naftali Neil Cohen) (the \"IRA\"), which is self-managed by the Reporting Person. The Reporting Person is the sole beneficiary of the IRA and may be deemed to have sole voting and dispositive power with respect to the ADSs held by IRA."}],"balance_after":10409,"source":{"system":"sec-edgar","filing":"0001178913-22-001117","document":"zk2227487.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1534248/000117891322001117/zk2227487.xml","form_type":"4"}},{"id":2332761,"issuer":{"id":7653,"kind":"organization","name":"Chemomab Therapeutics Ltd."},"owners":[{"id":17866,"kind":"person","name":"Cohen Neil Harris","position":1,"cik":"0001840006","reported_name":"Cohen Neil Harris","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"American Depositary Shares","published_at":"2022-03-15T20:07:42.000Z","date":"2022-03-14","kind":"purchase","acquired":true,"shares":2000,"price":4.3,"value":8600.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each American Depositary Share (ADS) represents twenty (20) ordinary shares, no par value, of the Issuer."},{"field":"shares","element":"transactionShares","label":"F2","text":"The ADSs are held of record directly by the Phoenix Insurance Company Ltd. (Naftali Neil Cohen) (the \"IRA\"), which is self-managed by the Reporting Person. The Reporting Person is the sole beneficiary of the IRA and may be deemed to have sole voting and dispositive power with respect to the ADSs held by IRA."}],"balance_after":8409,"source":{"system":"sec-edgar","filing":"0001178913-22-001117","document":"zk2227487.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1534248/000117891322001117/zk2227487.xml","form_type":"4"}},{"id":2332760,"issuer":{"id":7653,"kind":"organization","name":"Chemomab Therapeutics Ltd."},"owners":[{"id":17866,"kind":"person","name":"Cohen Neil Harris","position":1,"cik":"0001840006","reported_name":"Cohen Neil Harris","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"American Depositary Shares","published_at":"2022-03-15T20:07:42.000Z","date":"2022-03-14","kind":"purchase","acquired":true,"shares":2000,"price":4.2,"value":8400.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each American Depositary Share (ADS) represents twenty (20) ordinary shares, no par value, of the Issuer."},{"field":"shares","element":"transactionShares","label":"F2","text":"The ADSs are held of record directly by the Phoenix Insurance Company Ltd. (Naftali Neil Cohen) (the \"IRA\"), which is self-managed by the Reporting Person. The Reporting Person is the sole beneficiary of the IRA and may be deemed to have sole voting and dispositive power with respect to the ADSs held by IRA."}],"balance_after":6409,"source":{"system":"sec-edgar","filing":"0001178913-22-001117","document":"zk2227487.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1534248/000117891322001117/zk2227487.xml","form_type":"4"}},{"id":2341222,"issuer":{"id":7653,"kind":"organization","name":"Chemomab Therapeutics Ltd."},"owners":[{"id":17866,"kind":"person","name":"Cohen Neil Harris","position":1,"cik":"0001840006","reported_name":"Cohen Neil Harris","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to Purchase American Depositary Shares","published_at":"2022-03-09T21:05:43.000Z","date":"2022-03-07","kind":"grant","acquired":true,"shares":6820,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"These options vest and become exercisable in their entirety on March 16, 2023."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"Each American Depositary Share (ADS) represents twenty (20) ordinary shares, no par value, of the Issuer."}],"balance_after":6820,"derivative":{"exercise_price":3.53,"expiration_date":"2032-03-07","underlying":"American Depositary Shares","underlying_shares":6820},"source":{"system":"sec-edgar","filing":"0001178913-22-001022","document":"zk2227455.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1534248/000117891322001022/zk2227455.xml","form_type":"4"}},{"id":2480227,"issuer":{"id":7653,"kind":"organization","name":"Chemomab Therapeutics Ltd."},"owners":[{"id":17866,"kind":"person","name":"Cohen Neil Harris","position":1,"cik":"0001840006","reported_name":"Cohen Neil Harris","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"American Depositary Shares","published_at":"2021-12-08T12:29:37.000Z","date":"2021-12-06","kind":"purchase","acquired":true,"shares":2000,"price":7.43,"value":14860.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each American Depositary Share (ADS) represents twenty (20) ordinary shares, no par value, of the Issuer."},{"field":"shares","element":"transactionShares","label":"F2","text":"The ADSs are held of record directly by the Phoenix Insurance Company Ltd. (Naftali Neil Cohen) (the \"IRA\"), which is self-managed by the Reporting Person. The Reporting person is the sole beneficiary of the IRA and may be deemed to have sole voting and dispositive power with respect to the ADSs held by IRA."}],"balance_after":4409,"source":{"system":"sec-edgar","filing":"0001178913-21-003807","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1534248/000117891321003807/ownership.xml","form_type":"4"}},{"id":2742778,"issuer":{"id":7653,"kind":"organization","name":"Chemomab Therapeutics Ltd."},"owners":[{"id":17866,"kind":"person","name":"Cohen Neil Harris","position":1,"cik":"0001840006","reported_name":"Cohen Neil Harris","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to Purchase American Depositary Shares","published_at":"2021-04-21T21:06:38.000Z","date":"2021-04-19","kind":"grant","acquired":true,"shares":11884,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"These options vest and become exercisable in equal monthly installments over a 36 month period commencing on March 16, 2021, subject to the Reporting Person's continued service."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"Each American Depositary Share (ADS) represents twenty (20) ordinary shares, no par value, of the Issuer."}],"balance_after":11884,"derivative":{"exercise_price":27.26,"expiration_date":"2031-04-19","underlying":"American Depositary Shares","underlying_shares":11884},"source":{"system":"sec-edgar","filing":"0001104659-21-053223","document":"tm2113689-1_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1534248/000110465921053223/tm2113689-1_4.xml","form_type":"4"}},{"id":2770284,"issuer":{"id":7653,"kind":"organization","name":"Chemomab Therapeutics Ltd."},"owners":[{"id":17866,"kind":"person","name":"Cohen Neil Harris","position":1,"cik":"0001840006","reported_name":"Cohen Neil Harris","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to Purchase American Depositary Shares","published_at":"2021-03-26T14:27:04.000Z","date":"2021-03-16","kind":"purchase","acquired":true,"shares":688,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These options vest and become exercisable as follows: 1/3 vest on July 16, 2021, and the remaining options vest on a quarterly basis for the following eight quarters, subject to the Reporting Person's continued service."}],"balance_after":688,"derivative":{"exercise_price":13.17,"expiration_date":"2030-03-15","underlying":"American Depositary Shares","underlying_shares":688},"source":{"system":"sec-edgar","filing":"0001104659-21-042091","document":"tm2111044-1_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1534248/000110465921042091/tm2111044-1_4.xml","form_type":"4"}},{"id":2770283,"issuer":{"id":7653,"kind":"organization","name":"Chemomab Therapeutics Ltd."},"owners":[{"id":17866,"kind":"person","name":"Cohen Neil Harris","position":1,"cik":"0001840006","reported_name":"Cohen Neil Harris","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"American Depositary Shares","published_at":"2021-03-26T14:27:04.000Z","date":"2021-03-16","kind":"purchase","acquired":true,"shares":2409,"price":41.51,"value":99997.59,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Reporting Person acquired, in a private placement transaction, 1,397 American Depositary Shares and received an additional 1,011 American Depositary Shares pursuant to anti-dilution rights."}],"balance_after":2409,"source":{"system":"sec-edgar","filing":"0001104659-21-042091","document":"tm2111044-1_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1534248/000110465921042091/tm2111044-1_4.xml","form_type":"4"}},{"id":2794150,"issuer":{"id":7653,"kind":"organization","name":"Chemomab Therapeutics Ltd."},"owners":[{"id":17866,"kind":"person","name":"Cohen Neil Harris","position":1,"cik":"0001840006","reported_name":"Cohen Neil Harris","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"interim CEO"}}],"security":"Stock Option (right to buy)","published_at":"2021-03-11T23:33:02.000Z","date":"2020-07-16","kind":"grant","acquired":true,"shares":55000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of shares underlying the option vests on July 16, 2021, and 12.5% of the remaining shares underlying the option vest in eight equal quarterly installments thereafter."}],"balance_after":55000,"derivative":{"exercise_price":0.17,"expiration_date":"2030-07-15","underlying":"Ordinary Shares","underlying_shares":55000},"source":{"system":"sec-edgar","filing":"0001209191-21-019929","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1534248/000120919121019929/doc4.xml","form_type":"4"}}]}